Breaking News Instant updates and real-time market news.

CCXI

ChemoCentryx

$8.02

-0.47 (-5.54%)

12:34
12/22/16
12/22
12:34
12/22/16
12:34

ChemoCentryx, Vifor expand alliance to include CCX140 to treat renal diseases

Vifor Pharma, a company of the Galenica Group, and ChemoCentryx announced the expansion of their existing kidney health alliance to include the development and commercialization of CCX140, an orally-administered inhibitor of the chemokine receptor known as CCR2, for renal diseases. CCX140 has previously completed a successful Phase II clinical trial in patients with diabetic kidney disease. The alliance will initially focus on the joint development of CCX140 in rare kidney diseases, with Vifor Pharma retaining an option to solely develop and commercialize CCX140 in more prevalent forms of chronic kidney disease. Under the agreement, ChemoCentryx retains marketing rights for rare renal disease in the U.S. and China, while Vifor Pharma has commercialization rights in the rest of the world. Under the terms of the agreement, ChemoCentryx will receive an upfront cash payment of $50M. In addition, ChemoCentryx will be eligible to receive additional payments upon the achievement of certain development, regulatory and sales-based milestones, as well as tiered double-digit royalties on net sales of CCX140 in the licensed territories. ChemoCentryx will be responsible for the clinical development of CCX140 in rare renal diseases, while sharing the cost of such development with Vifor Pharma. Should Vifor Pharma later exercise the CKD option, Vifor Pharma would then be responsible for all development and would receive worldwide rights to CCX140, while ChemoCentryx would receive co-promotion rights in CKD in the U.S.

TODAY'S FREE FLY STORIES

A

Agilent

$69.92

1.125 (1.64%)

16:06
11/20/17
11/20
16:06
11/20/17
16:06
Earnings
Agilent reports Q4 adjusted EPS 67c, consensus 62c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

VIPS

Vipshop

$9.27

-0.51 (-5.21%)

16:06
11/20/17
11/20
16:06
11/20/17
16:06
Earnings
Vipshop reports Q3 adjusted EPS 14c, consensus 14c »

Reports Q3 revenue $2.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ARNC

Arconic

$23.87

0.02 (0.08%)

16:05
11/20/17
11/20
16:05
11/20/17
16:05
Hot Stocks
Arconic to install new horizontal heat treat furnace at Davenport Works facility »

Arconic announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$157.78

1.23 (0.79%)

16:05
11/20/17
11/20
16:05
11/20/17
16:05
Earnings
Intuit reports Q1 EPS (7c), consensus (5c) »

Reports Q1 revenue $886M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SIFI

SI Financial

$14.95

0.35 (2.40%)

16:04
11/20/17
11/20
16:04
11/20/17
16:04
Hot Stocks
SI Financial Chief Credit Officer Gerald Coia to retire »

SI Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTA

Enanta

16:03
11/20/17
11/20
16:03
11/20/17
16:03
Earnings
Enanta Pharmaceuticals reports Q4 EPS $1.86, consensus $2.13 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NBIX

Neurocrine

, ZBH

Zimmer Biomet

$112.03

0.42 (0.38%)

16:02
11/20/17
11/20
16:02
11/20/17
16:02
Hot Stocks
Neurocrine names Matt Abernethy as CFO »

Neurocrine Biosciences…

NBIX

Neurocrine

ZBH

Zimmer Biomet

$112.03

0.42 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 01

    Dec

  • 14

    Dec

CAFD

8point3 Energy

$14.94

0.04 (0.27%)

, PEGI

Pattern Energy

$22.13

0.14 (0.64%)

15:46
11/20/17
11/20
15:46
11/20/17
15:46
Periodicals
8point3 draws interest from Capital Dynamics, Pattern Energy, Bloomberg says »

Capital Dynamics and…

CAFD

8point3 Energy

$14.94

0.04 (0.27%)

PEGI

Pattern Energy

$22.13

0.14 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

VRX

Valeant

$15.64

0.95 (6.47%)

15:40
11/20/17
11/20
15:40
11/20/17
15:40
Options
Valeant calls active as shares see relative strength »

Valeant calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Jun

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, GIS

General Mills

$54.23

0.51 (0.95%)

15:34
11/20/17
11/20
15:34
11/20/17
15:34
Periodicals
General Mills, not Nestle, should buy Hain Celestial, Cramer says »

Following a Bloomberg…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

GIS

General Mills

$54.23

0.51 (0.95%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$156.55

0.9 (0.58%)

15:34
11/20/17
11/20
15:34
11/20/17
15:34
Options
Intuit options imply 5.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SHPG

Shire

$147.37

2.74 (1.89%)

, RHHBY

Roche

$29.10

0.205 (0.71%)

15:32
11/20/17
11/20
15:32
11/20/17
15:32
Recommendations
Shire, Roche analyst commentary  »

Shire selloff on Roche…

SHPG

Shire

$147.37

2.74 (1.89%)

RHHBY

Roche

$29.10

0.205 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

15:30
11/20/17
11/20
15:30
11/20/17
15:30
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TWX

Time Warner

$87.93

-0.79 (-0.89%)

15:28
11/20/17
11/20
15:28
11/20/17
15:28
Technical Analysis
Technical View: Time Warner drops on pending antitrust briefing »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$34.74

0.23 (0.67%)

, TWX

Time Warner

$87.93

-0.79 (-0.89%)

15:28
11/20/17
11/20
15:28
11/20/17
15:28
Periodicals
DOJ antitrust announcement concerns AT&T, Time Warner, NBC reports »

Bloomberg also reported…

T

AT&T

$34.74

0.23 (0.67%)

TWX

Time Warner

$87.93

-0.79 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

MRVL

Marvell

$20.29

0.03 (0.15%)

, CAVM

Cavium

$75.83

-0.47 (-0.62%)

15:27
11/20/17
11/20
15:27
11/20/17
15:27
Recommendations
Marvell, Cavium, Broadcom analyst commentary  »

Marvell price target…

MRVL

Marvell

$20.29

0.03 (0.15%)

CAVM

Cavium

$75.83

-0.47 (-0.62%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 06

    Dec

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

15:24
11/20/17
11/20
15:24
11/20/17
15:24
Technical Analysis
Technical View: Hain Celestial spikes higher, retraces some gains »

The shares have come off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, NSRGY

Nestle

$85.11

0.7 (0.83%)

15:22
11/20/17
11/20
15:22
11/20/17
15:22
Hot Stocks
Hain Celestial surges after report of Nestle weighing potential bid »

Shares of Hain Celestial…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$56.11

1.07 (1.94%)

15:20
11/20/17
11/20
15:20
11/20/17
15:20
Options
Sarepta Therapeutics sees a bullish option play »

Sarepta Therapeutics sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

HAIN

Hain Celestial

$40.06

0.21 (0.53%)

15:19
11/20/17
11/20
15:19
11/20/17
15:19
Hot Stocks
Breaking Hot Stocks news story on Hain Celestial »

Hain Celestial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRG

HRG Group

$16.06

-0.025 (-0.16%)

15:19
11/20/17
11/20
15:19
11/20/17
15:19
Options
Harbinger options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, NSRGY

Nestle

$85.11

0.7 (0.83%)

15:17
11/20/17
11/20
15:17
11/20/17
15:17
Hot Stocks
Breaking Hot Stocks news story on Hain Celestial, Nestle »

Hain Celestial jumps 7%,…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
11/20/17
11/20
15:17
11/20/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
11/20/17
11/20
15:16
11/20/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$85.11

0.7 (0.83%)

, HAIN

Hain Celestial

$39.84

1.35 (3.51%)

15:16
11/20/17
11/20
15:16
11/20/17
15:16
Periodicals
Breaking Periodicals news story on Nestle, Hain Celestial »

Nestle looking into bid…

NSRGY

Nestle

$85.11

0.7 (0.83%)

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.